Page 196 - Read Online

Horch et al. Towards the future of plastic surgery

device to a reconstructive alternative? Handchir Mikrochir Plast Chir JP, Kneser U, Horch RE, Detsch R, Boccaccini AR, Arkudas A. In
2012;44:198-203. vitro and in vivo biocompatibility of alginate dialdehyde/gelatin
20. Weigand A, Beier JP, Arkudas A, Al-Abboodi M, Polykandriotis E, hydrogels with and without nanoscaled bioactive glass for bone tissue
Horch RE, Boos AM. The arteriovenous (av) loop in a small animal engineering applications. Materials (Basel) 2014;7:1957-74.
model to study angiogenesis and vascularized tissue engineering. J 27. Witt R, Weigand A, Boos AM, Cai A, Dippold D, Boccaccini AR,
Vis Exp 2016;(117):54676. Schubert DW, Hardt M, Lange C, Arkudas A, Horch RE, Beier JP.
21. Weigand A, Beier JP, Hess A, Gerber T, Arkudas A, Horch RE, Mesenchymal stem cells and myoblast differentiation under HGF and
Boos AM. Acceleration of vascularized bone tissue-engineered IGF-1 stimulation for 3D skeletal muscle tissue engineering. BMC
constructs in a large animal model combining intrinsic and extrinsic Cell Biol 2017;18:15.
vascularization. Tissue Eng Part A 2015;21:1680-94. 28. Horch RE, Beier JP, Kneser U, Arkudas A. Successful human long-
22. Arkudas A, Beier JP, Heidner K, Tjiawi J, Polykandriotis E, Srour term application of in situ bone tissue engineering. J Cell Mol Med
S, Sturzl M, Horch RE, Kneser U. Axial prevascularization of 2014;18:1478-85.
porous matrices using an arteriovenous loop promotes survival and 29. Groll J, Boland T, Blunk T, Burdick JA, Cho DW, Dalton PD,
differentiation of transplanted autologous osteoblasts. Tissue Eng Derby B, Forgacs G, Li Q, Mironov VA, Moroni L, Nakamura M,
2007;13:1549-60. Shu W, Takeuchi S, Vozzi G, Woodfield TB, Xu T, Yoo JJ, Malda
23. Arkudas A, Tjiawi J, Saumweber A, Beier JP, Polykandriotis E, J. Biofabrication: reappraising the definition of an evolving field.
Bleiziffer O, Horch RE, Kneser U. Evaluation of blood vessel Biofabrication 2016;8:013001.
ingrowth in fibrin gel subject to type and concentration of growth 30. Wu C, Wang B, Zhang C, Wysk RA, Chen YW. Bioprinting: an
factors. J Cell Mol Med 2009;13:2864-74. assessment based on manufacturing readiness levels. Crit Rev
24. Bertram U, Steiner D, Poppitz B, Dippold D, Köhn K, Beier JP, Biotechnol 2017;37:333-54.
Detsch R, Boccaccini AR, Schubert DW, Horch RE, Arkudas A. 31. Ravnic DJ, Leberfinger AN, Ozbolat IT. Bioprinting and cellular
Vascular tissue engineering: effects of integrating collagen into a PCL therapies for type 1 diabetes. Trends Biotechnol 2017; doi: 10.1016/j.
based nanofiber material. Biomed Res Int 2017;2017:9616939. tibtech.2017.07.006.
25. Dippold D, Cai A, Hardt M, Boccaccini AR, Horch R, Beier JP, 32. Horch RE. Future perspectives in tissue engineering. J Cell Mol Med
Schubert DW. Novel approach towards aligned PCL-Collagen 2006;10:4-6.
nanofibrous constructs from a benign solvent system. Mater Sci Eng 33. Horch RE, Weigand A, Beier JP, Arkudas A, Boos AM. The potential
C Mater Biol Appl 2017;72:278-83. role of telocytes for tissue engineering and regenerative medicine. Adv
26. Rottensteiner U, Sarker B, Heusinger D, Dafinova D, Rath SN, Beier Exp Med Biol 2016;913:139-47.

Plastic and Aesthetic Research ¦ Volume 4 ¦ October 31, 2017 189